C. Ola Landgren, M.D., Ph.D., received HealthTree Foundation's prestigious 2025 Innovation Award for his work in developing CORAL, a new research tool that leverages AI to predict individual outcomes ...
The "United States Multiple Myeloma Market Report by Drugs Types, Disease Types, End User, States and Company Analysis, 2025-2033" has been added to ResearchAndMarkets.com's offering.The United States ...
Plus, some of our favorite recipes to get you started. Reviewed by Dietitian Jessica Ball, M.S., RD A new study suggests vegetarians have a 12% lower overall cancer risk compared to those who eat meat ...
During her clinic shift, Melissa Lopez PhD, RDN, received word that a participant in a trial evaluating the impact of ...
Since the beginning of this century, advances in understanding the biology of multiple myeloma have transformed the disease from universally fatal to curable for a substantial proportion of patients.
For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms — pain in her spine and hips, nausea, exhaustion, thirst, and frequent urination. Her primary care physician had ruled ...
ABSTRACT: Objective: To evaluate the effects of nutritional support on treatment tolerance and complications in patients with bone tumors undergoing chemotherapy via a meta-analysis. Methods: The ...
ABSTRACT: Objective: To evaluate the effects of nutritional support on treatment tolerance and complications in patients with bone tumors undergoing chemotherapy via a meta-analysis. Methods: The ...
Not a day goes by in clinic without a patient asking about the recent New York Times article on multiple myeloma: "Doc, is there really a cure now? I want this treatment." The article was boldly ...
Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...
Disparities in multiple myeloma outcomes are linked to income and geographic location, with lower-income and rural patients experiencing higher mortality rates. Limited access to insurance, novel ...
The Spanish Society of Hematology and Hemotherapy (SEHH) held its ninth “HematoAvanza” Outreach Conference at the Pazo de San Lorenzo in Santiago, Spain. The event brought together hematologists, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback